Plain-English translation of NCT07171970 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different approaches to fertility treatment for women with polycystic ovary syndrome (PCOS). One approach uses a gentler method called in vitro maturation (IVM) where eggs are retrieved while still immature and matured in the lab, then transferred fresh into the uterus within days. The other approach uses standard in vitro fertilization (IVF) where eggs are stimulated to mature before retrieval, fertilized, frozen for later use, and then thawed and transferred when the uterus is ready.
PCOS can make fertility treatment challenging because the ovaries often respond too strongly to hormone stimulation, which can cause serious side effects. Researchers want to find out whether the gentler IVM approach with fresh transfer might work just as well or better than standard IVF with frozen transfer, while reducing these risks.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups. If assigned to the IVM-fresh group, you will take hormone tablets to prepare your uterus, have your immature eggs retrieved, have them matured in the lab, fertilized, and transferred back into your uterus within a few days. If assigned to the standard IVF group, you will receive daily hormone injections to stimulate your ovaries, have mature eggs retrieved and fertilized, have the resulting embryos frozen, and then later have one thawed and transferred after your uterus is prepared. Both groups will take hormone support after transfer and have pregnancy tests 10–14 days later. The study will follow you through pregnancy and birth to compare how well each approach works.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Vietnam